Views

CrossRef citations to date

Altmetric

Original Articles: Clinical

Phase III, randomized study of ofatumumab versus physicians’ choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia

Anders ÖsterborgDepartment of Hematology, Karolinska University Hospital, Stockholm, Sweden; Correspondence[email protected]

Miklós UdvardyInstitute of Internal Medicine Building B, Haemopoetic Transplantation Centre, DEOEC (Debreceni Egyetem Orvos És Egészségtudományi Centrum), Debrecen, Hungary;

Andrey ZaritskeyCenter of Heart Blood and Endocrinology, St Petersburg, Russia;

Per-Ola AnderssonSödra Älvsborgs Sjukhus, Borås, Sweden;

Sebastian GrosickiDepartment of Cancer Prevention, Faculty of Public Health, Silesian Medical University, Katowice, Poland;

Grzegorz MazurWroclaw Medical University, Wroclaw, Poland;

Polina KaplanDnipropetrovsk City Clinical Hospital No. 4, Dnipropetrovsk, Ukraine;

Michael SteurerInnsbruck Medical University, Innsbruck, Austria;

Anna SchuhChurchill Hospital, Oxford, UK;

Marco MontilloOspedale Niguarda Ca’Granda, Milan, Italy;

Iryna KryachokNational Cancer Institute, Kiev, Ukraine;

Jan Moritz MiddekeUniversitaetsklinikum Carl Gustav Carus, Dresden, Germany;

Yaroslav KulyabaMakiivka City Hospital #2 of Donetsk Region, Makiivka, Ukraine;

Grygoriy RekhtmanKhmelnytskyi Regional Hospital, Khmelnytskyi, Ukraine;

Michele GorczycaPfizer Inc, Collegeville, PA, USA;

Siobhan DalyNovartis Pharmaceuticals, Dublin, Ireland;

Chai-Ni ChangNovartis Pharmaceuticals, Research Triangle Park, NC, USA;

Steen LisbyGenmab, Copenhagen, Denmark;

Ira GuptaNovartis Pharmaceuticals, Wayne, PA, USA

show all

Phase III, randomized study of ofatumumab versus physicians’ choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

GLAL-2015-0919-File017.pdf

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Phase III, randomized study of ofatumumab versus physicians’ choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

GLAL-2015-0919-File017.pdf

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date